MOTCO’s Regeneron Pharmaceuticals REGN Stock Holding History

MOTCO’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$773	Hold	1	–	–	﹤0.01%	568
2025 Q4	$772	Hold	1	–	–	﹤0.01%	597
2025 Q3	$562	Hold	1	–	–	﹤0.01%	621
2025 Q2	$545	Hold	1	–	–	﹤0.01%	589
2025 Q1	$634	Buy	+1	New	+$688	﹤0.01%	571
2024 Q1	–	Sell	-10	Closed	-$8.78K	–	763
2023 Q4	$8.78K	Hold	10	–	–	﹤0.01%	489
2023 Q3	$8.23K	Hold	10	–	–	﹤0.01%	521
2023 Q2	$7.18K	Buy	+10	New	+$7.71K	﹤0.01%	527
2021 Q1	–	Sell	-5	Closed	-$2K	–	761
2020 Q4	$2K	Hold	5	–	–	﹤0.01%	694
2020 Q3	$3K	Hold	5	–	–	﹤0.01%	560
2020 Q2	$3K	Hold	5	–	–	﹤0.01%	518
2020 Q1	$2K	Buy	+5	New	+$2.06K	﹤0.01%	557
2019 Q3	–	Sell	-16	Closed	-$5K	–	694
2019 Q2	$5K	Buy	+16	New	+$5.33K	﹤0.01%	720
2016 Q4	–	Sell	-19	Closed	-$8K	–	630
2016 Q3	$8K	Buy	+19	New	+$7.62K	﹤0.01%	498

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

MOTCO's REGN Position: Q1 2026 in Review

MOTCO held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 1 share worth $773. The position accounts for ﹤0.01% of the portfolio, ranked #568.

MOTCO first reported a position in REGN in Q3 2016 and has held it in 14 quarters since. The position peaked at $8.78K in Q4 2023. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

MOTCO held 1 share of Regeneron Pharmaceuticals worth $773 as of Q1 2026.
MOTCO left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
Regeneron Pharmaceuticals made up ﹤0.01% of MOTCO's portfolio in Q1 2026, its #568 holding.
MOTCO first reported a position in Regeneron Pharmaceuticals in Q3 2016 and has held it in 14 quarters since.
MOTCO's Regeneron Pharmaceuticals position peaked at $8.78K in Q4 2023.
1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on MOTCO's 13F filing for Q1 2026, filed 22 Apr 2026.